India is world’s fourth largest pharmaceuticals producer with eight per cent share of global production by volume and 1.5 per cent share by value. Indian pharmaceutical companies have a cost advantage that facilitates the production of drugs at almost one-twentieth the cost incurred by other developed economies. Indian pharmaceuticals market was valued at around US$ 6.5 billion in 2001. All kinds of pharmaceutical products including anti-retroviral, malaria, life saving drugs, etc. can be sourced from India at very competitive prices without compromising on the quality. During the period 2002-05, the market for generic drugs is expected to exceed US$ 55 billion. India, with its technology, R&D facilities and trained human resources can capture a significant part of this market. Domestic market in India itself is estimated to be worth US$ 12 billion by 2010.

http://chemicals.nic.in
http://nppaindia.nic.in
www.capexil.com
www.mohfw.nic.in
Central Drugs Standard Control Organisation (http://cdsco.nic.in)
Pharmacy Council Of India (http://pci.nic.in)
Central Bureau of Health Intelligence (http://cbhidghs.nic.in)